Share on StockTwits

Cardinal Health (NYSE:CAH) CEO Michael C. Kaufmann sold 6,833 shares of Cardinal Health stock on the open market in a transaction that occurred on Monday, August 18th. The shares were sold at an average price of $72.06, for a total transaction of $492,385.98. Following the completion of the transaction, the chief executive officer now directly owns 118,576 shares of the company’s stock, valued at approximately $8,544,587. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

CAH has been the subject of a number of recent research reports. Analysts at Argus reiterated a “buy” rating on shares of Cardinal Health in a research note on Monday. They now have a $71.43 price target on the stock, down previously from $83.00. Separately, analysts at Barclays reiterated an “overweight” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $82.00 price target on the stock, up previously from $77.00. Finally, analysts at Credit Suisse reiterated an “outperform” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $80.00 price target on the stock, up previously from $76.00. Three investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $77.93.

Shares of Cardinal Health (NYSE:CAH) traded up 0.54% during mid-day trading on Tuesday, hitting $72.60. The stock had a trading volume of 1,824,200 shares. Cardinal Health has a 52 week low of $49.65 and a 52 week high of $74.40. The stock’s 50-day moving average is $71.03 and its 200-day moving average is $69.58. The company has a market cap of $24.441 billion and a price-to-earnings ratio of 21.37.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Monday, August 4th. The company reported $0.83 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.81 by $0.02. The company had revenue of $2.90 billion for the quarter, compared to the consensus estimate of $21.88 billion. During the same quarter in the prior year, the company posted $0.79 earnings per share. The company’s quarterly revenue was down 9.9% on a year-over-year basis. Analysts expect that Cardinal Health will post $4.25 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a dividend of $0.3425 per share. This represents a $1.37 dividend on an annualized basis and a yield of 1.89%. The ex-dividend date of this dividend is Monday, September 29th.

Cardinal Health, Inc is a healthcare services company providing pharmaceutical and medical products and services to pharmacies, hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.